DYN
Dyne Therapeutics Inc

2,571
Loading...
Loading...
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
191

Frequently Asked Questions

What is Market Cap of Dyne Therapeutics Inc?
What is the 52-week high for Dyne Therapeutics Inc?
What is the 52-week low for Dyne Therapeutics Inc?
What is Dyne Therapeutics Inc stock price today?
What was Dyne Therapeutics Inc stock price yesterday?
What is the PE ratio of Dyne Therapeutics Inc?
What is the Price-to-Book ratio of Dyne Therapeutics Inc?
What is the 50-day moving average of Dyne Therapeutics Inc?
How many employess does Dyne Therapeutics Inc has?

Latest DYN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.